Homework Help is Here – Start Your Trial Now!
Business
Accounting
analysis er the question 100 00 Ef 4 10

analysis er the question 100 00 Ef 4 10

FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
See similar textbooks
icon
Related questions
Question

part \D

8. Cost-benefit & Cost-effectiveness analysis Given the information below, answer the questions that follow. Effectiveness 4 life-years gained 10 life-years gained Current Treatment New Treatment Cost $100,000 $250,000 A. Calculate the ICER for the new treatment, assuming that the new treatment would replace the old one. Should the new treatment be adopted? Why? B. Calculate the cost effectiveness for both current and new treatments. (Hint: use the ratio of costs over benefits)
Transcribed Image Text:8. Cost-benefit & Cost-effectiveness analysis Given the information below, answer the questions that follow. Effectiveness 4 life-years gained 10 life-years gained Current Treatment New Treatment Cost $100,000 $250,000 A. Calculate the ICER for the new treatment, assuming that the new treatment would replace the old one. Should the new treatment be adopted? Why? B. Calculate the cost effectiveness for both current and new treatments. (Hint: use the ratio of costs over benefits)
C. What is QALY? Briefly explain how QALY might change your answer to the above questions. D. Assume that to be fully vaccinated, people (in a given population of 1,000 individuals) need to get three doses of the new and improved COVID-19 m-RNA vaccines. What is the marginal cost of each dose? What is the optimal number of doses suggested by the results of the cost effectiveness analysis? Using the averted hospitalization. Using the averted mortality. Based on your answers above, which is your preferred cost effectiveness measure? Explain in 1-2 sentences. (i) (ii) Dose of Vaccine Total Cost per person 0 $400 $450 $460 0 1 2 3 Averted Hospitalization 0 20,000 10,000 5,000 Averted Mortality 0 3,000 1,500 200
Transcribed Image Text:C. What is QALY? Briefly explain how QALY might change your answer to the above questions. D. Assume that to be fully vaccinated, people (in a given population of 1,000 individuals) need to get three doses of the new and improved COVID-19 m-RNA vaccines. What is the marginal cost of each dose? What is the optimal number of doses suggested by the results of the cost effectiveness analysis? Using the averted hospitalization. Using the averted mortality. Based on your answers above, which is your preferred cost effectiveness measure? Explain in 1-2 sentences. (i) (ii) Dose of Vaccine Total Cost per person 0 $400 $450 $460 0 1 2 3 Averted Hospitalization 0 20,000 10,000 5,000 Averted Mortality 0 3,000 1,500 200
Expert Solution
steps

Step by step

Solved in 4 steps with 4 images

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Employee Retirement Income Security Act (ERISA)
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education
SEE MORE TEXTBOOKS